Antimicrobial Macrolide Levantilide D from Rare Marine Micromonospora sp.

References

1. Yan S. Zeng M. Wang H. Zhang H. Micromonospora : A Prolific Source of Bioactive Secondary Metabolites with Therapeutic Potential. J. Med. Chem. 2022 65 13 8735 8771 10.1021/acs.jmedchem.2c00626 35766919
   [Google Scholar]
2. Hifnawy M.S. Fouda M.M. Sayed A.M. Mohammed R. Hassan H.M. AbouZid S.F. Rateb M.E. Keller A. Adamek M. Ziemert N. Abdelmohsen U.R. The genus Micromonospora as a model microorganism for bioactive natural product discovery. RSC Advances 2020 10 35 20939 20959 10.1039/D0RA04025H 35517724
   [Google Scholar]
3. Rathinam A.J. Santhaseelan H. Dahms H.U. Dinakaran V.T. Murugaiah S.G. Bioprospecting of unexplored halophilic actinobacteria against human infectious pathogens. 3 Biotech 2023 13 12 398
   [Google Scholar]
4. Correia de Lemos S.M. Paschoal A.R. Guyot R. Medema M. Domingues D.S. Genome mining of metabolic gene clusters in the Rubiaceae family. Comput. Struct. Biotechnol. J. 2024 23 22 33 10.1016/j.csbj.2023.11.034 38075396
   [Google Scholar]
5. Yang Q. Tian J. Chen S. Yang Z. Wang Z. Xu H.M. Dong L.B. Discovery of sesquiterpenoids from an actinomycete Crossiella cryophila through genome mining and heterologous expression. Bioorg. Chem. 2024 146 107308 10.1016/j.bioorg.2024.107308 38531151
   [Google Scholar]
6. Scaphechinus mirabilis extract effectively inhibits the proliferation of BPH-1 and LNCaP prostate epithelial cells. Nat. Prod. J. 2022 12 2 e030621193849
   [Google Scholar]
7. Dehghani H. Rashedinia M. Mohebbi G. Vazirizadeh A. Studies on Secondary Metabolites and In vitro and In silico Anticholinesterases Activities of the Sea Urchin Echinometra mathaei Crude Venoms from the Persian Gulf-Bushehr. Nat. Prod. J. 2024 14 2 e220623218175 10.2174/2210315514666230622144244
   [Google Scholar]
8. Al-Fadhli A.A. Threadgill M.D. Mohammed F. Sibley P. Al-Ariqi W. Parveen I. Macrolides from rare actinomycetes: Structures and bioactivities. Int. J. Antimicrob. Agents 2022 59 2 106523 10.1016/j.ijantimicag.2022.106523 35041941
   [Google Scholar]
9. Lan D. Wu B. Chemistry and Bioactivities of Secondary Metabolites from the Genus Talaromyces. Chem. Biodivers. 2020 17 8 e2000229 10.1002/cbdv.202000229 32432837
   [Google Scholar]
10. Salillas S. Raaijmakers J. Aarnoutse R.E. Svensson E.M. Asouit K. van den Hombergh E. te Brake L. Stemkens R. Wertheim H.F.L. Hoefsloot W. van Ingen J. Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrob. Agents Chemother. 2024 68 3 e01157-23 10.1128/aac.01157‑23 38259101
    [Google Scholar]
11. Kassegne L. Veziris N. Fraisse P. [A pharmacologic approach to treatment of Mycobacterium abscessus pulmonary disease]. Rev. Mal. Respir. 2024 41 1 29 42 10.1016/j.rmr.2023.10.010 38016833
    [Google Scholar]
12. Southern K.W. Solis-Moya A. Kurz D. Smith S. Macrolide antibiotics (including azithromycin) for cystic fibrosis. Cochrane Database Syst. Rev. 2024 2 2 CD002203 38411248
    [Google Scholar]
13. Blin K. Shaw S. Augustijn H.E. Reitz Z.L. Biermann F. Alanjary M. Fetter A. Terlouw B.R. Metcalf W.W. Helfrich E.J.N. van Wezel G.P. Medema M.H. Weber T. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res. 2023 51 W1 W46 W50 10.1093/nar/gkad344 37140036
    [Google Scholar]
14. Zhao W. Jiang H. Ge Y. Zhou C. Ma Y. Zhou J. Xie Y. Wang Y. Wu B. Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51. Fitoterapia 2024 175 105946 10.1016/j.fitote.2024.105946 38575087
    [Google Scholar]
15. Frisch M.J. Trucks H.B. Gaussian 16, Revision B.01 Gaussian, Inc.: Wallingford CT 2016
    [Google Scholar]
16. Tirado-Rives J. Jorgensen W.L. Performance of B3LYP Density Functional Methods for a Large Set of Organic Molecules. J. Chem. Theory Comput. 2008 4 2 297 306 10.1021/ct700248k 26620661
    [Google Scholar]
17. Li X. Ge Y. Ma Y. Wang S. Li S. Yin Q. Liu X. Wie J. Wu X. Wu B. New Cytotoxic Secondary Metabolites from Two Deep‐Sea‐Derived Fungi and the Co‐Culture Impact on the Secondary Metabolic Patterns. Chem. Biodivers. 2022 19 4 e202200055 10.1002/cbdv.202200055 35229447
    [Google Scholar]
18. Dong J.Y. Tang M.C. Liu L. α-Pyrone Derivatives from Calcarisporium arbuscula Discovered by Genome Mining. J. Nat. Prod. 2023 86 11 2496 2501 10.1021/acs.jnatprod.3c00685 37924510
    [Google Scholar]
19. Inaba S. Eguchi T. Motegi A. Mizoue K. Usui T. Nagai K. Kataoka T. The cytotoxic macrolide FD-891 induces caspase-8-dependent mitochondrial release of cytochrome c and subsequent apoptosis in human leukemia Jurkat cells. J. Antibiot. (Tokyo) 2009 62 9 507 512 10.1038/ja.2009.62 19590527
    [Google Scholar]
20. Fei P. Chuan-xi W. Yang X. Hong-lei J. Lu-jie C. Uribe P. Bull A.T. Goodfellow M. Hong J. Yun-yang L. A new 20-membered macrolide produced by a marine-derived Micromonospora strain. Nat. Prod. Res. 2013 27 15 1366 1371 10.1080/14786419.2012.740038 23157320
    [Google Scholar]
21. Cheng Y.Q. Tang G.L. Shen B. Type I polyketide synthase requiring a discrete acyltransferase for polyketide biosynthesis. Proc. Natl. Acad. Sci. USA 2003 100 6 3149 3154 10.1073/pnas.0537286100 12598647
    [Google Scholar]
22. Kudo F. Motegi A. Mizoue K. Eguchi T. Cloning and characterization of the biosynthetic gene cluster of 16-membered macrolide antibiotic FD-891: involvement of a dual functional cytochrome P450 monooxygenase catalyzing epoxidation and hydroxylation. ChemBioChem 2010 11 11 1574 1582 10.1002/cbic.201000214 20589823
    [Google Scholar]